These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 18953271)

  • 1. New drugs.
    Pozniak A
    J HIV Ther; 2008 Jun; 13(2):27-33. PubMed ID: 18953271
    [No Abstract]   [Full Text] [Related]  

  • 2. Rilpivirine: a step forward in tailored HIV treatment.
    Schrijvers R; Desimmie BA; Debyser Z
    Lancet; 2011 Jul; 378(9787):201-3. PubMed ID: 21763920
    [No Abstract]   [Full Text] [Related]  

  • 3. [Resistance profile of rilpivirine].
    Imaz A; García F; di Yacovo S; Llibre JM
    Enferm Infecc Microbiol Clin; 2013 Jun; 31 Suppl 2():36-43. PubMed ID: 24252532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacological properties of rilpivirine (Edurant Tablet), a new drug for the treatment of HIV, and results of its clinical studies].
    Iwata M; Shikinami K; Nagino K; Harada Y
    Nihon Yakurigaku Zasshi; 2013 Apr; 141(4):205-11. PubMed ID: 23575426
    [No Abstract]   [Full Text] [Related]  

  • 5. [Mechanism of action and pharmacokinetics of rilpivirine].
    Portilla J; Estrada V
    Enferm Infecc Microbiol Clin; 2013 Jun; 31 Suppl 2():2-5. PubMed ID: 24252527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conclusions. Position of rilpivirine in the management of infection by the human immunodeficiency virus].
    Podzamczer D
    Enferm Infecc Microbiol Clin; 2013 Jun; 31 Suppl 2():44. PubMed ID: 24252533
    [No Abstract]   [Full Text] [Related]  

  • 7. [Improved long-term success. New nucleoside for once daily combinations].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():31-3. PubMed ID: 15373043
    [No Abstract]   [Full Text] [Related]  

  • 8. Highly active antiretroviral therapy failure and protease and reverse transcriptase human immunodeficiency virus type 1 gene mutations.
    Monno L; Appice A; Cavaliere R; Scarabaggio T; Angarano G
    J Infect Dis; 1999 Aug; 180(2):568-71. PubMed ID: 10395885
    [No Abstract]   [Full Text] [Related]  

  • 9. [New antiretroviral drug classes in HIV therapy].
    Lehmann C; Meuer K; Kümmerle T; Fätkenheuer G
    MMW Fortschr Med; 2009 Apr; 151(18):64-6. PubMed ID: 19769081
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecule of the month. PA-457.
    Drug News Perspect; 2004 May; 17(4):283. PubMed ID: 15334176
    [No Abstract]   [Full Text] [Related]  

  • 11. Next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Boone LR
    Curr Opin Investig Drugs; 2006 Feb; 7(2):128-35. PubMed ID: 16499282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the rate of genotypic resistance to antiretroviral drugs in Spain.
    Gallego O; Ruiz L; Vallejo A; Ferrer E; Rubio A; Clotet B; Leal M; Soriano V;
    AIDS; 2001 Sep; 15(14):1894-6. PubMed ID: 11579258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical data II. Clinical experience of tenofovir DF in combination with protease inhibitors].
    Pulido F; Fiorante S
    Enferm Infecc Microbiol Clin; 2008 Jun; 26 Suppl 8():13-8. PubMed ID: 19195433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Approval of a new nucleoside. Component of complete once daily regimen].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():91. PubMed ID: 15373067
    [No Abstract]   [Full Text] [Related]  

  • 15. [Advances in novel anti-HIV-1 drugs and drug candidates: 2005-2008].
    Zheng PR; Xue H; Xiao ZY; Liu G
    Yao Xue Xue Bao; 2010 Feb; 45(2):154-64. PubMed ID: 21351426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype and antiretroviral drug resistance of human immunodeficiency virus-1 in Saudi Arabia.
    Jamjoom GA; Azhar EI; Madani TA; Hindawi SI; Bakhsh HA; Damanhouri GA
    Saudi Med J; 2010 Sep; 31(9):987-92. PubMed ID: 20844809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Introduction. Rilpivirine].
    Podzamczer D
    Enferm Infecc Microbiol Clin; 2013 Jun; 31 Suppl 2():1. PubMed ID: 24252526
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioequivalent formulation for the fixed-dose regimen of Truvada and TMC278 finalized.
    AIDS Patient Care STDS; 2010 Jun; 24(6):395-6. PubMed ID: 20575158
    [No Abstract]   [Full Text] [Related]  

  • 19. Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
    Sharma PL; Nurpeisov V; Hernandez-Santiago B; Beltran T; Schinazi RF
    Curr Top Med Chem; 2004; 4(9):895-919. PubMed ID: 15134548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-resistance within the protease inhibitor class.
    Race E
    Antivir Ther; 2001; 6 Suppl 2():29-36. PubMed ID: 11678476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.